Safe sequencing system

Patent metadata

Field	Value
Publication number	US-12209281-B2
Application number	US-202217837591-A
Country	US
Kind code	B2
Filing date	Jun 10, 2022
Priority date	Apr 15, 2011
Publication date	Jan 28, 2025
Grant date	Jan 28, 2025

Abstract

The identification of mutations that are present in a small fraction of DNA templates is essential for progress in several areas of biomedical research. Though massively parallel sequencing instruments are in principle well-suited to this task, the error rates in such instruments are generally too high to allow confident identification of rare variants. We here describe an approach that can substantially increase the sensitivity of massively parallel sequencing instruments for this purpose. One example of this approach, called “Safe-SeqS” for (Safe-Sequencing System) includes (i) assignment of a unique identifier (UID) to each template molecule; (ii) amplification of each uniquely tagged template molecule to create UID-families; and (iii) redundant sequencing of the amplification products. PCR fragments with the same UID are truly mutant (“super-mutants”) if ≥95% of them contain the identical mutation. We illustrate the utility of this approach for determining the fidelity of a polymerase, the accuracy of oligonucleotides synthesized in vitro, and the prevalence of mutations in the nuclear and mitochondrial genomes of normal cells.

First claim

We claim:

1. A method for detecting a DNA fragment comprising a region of interest, the method comprising:
attaching an adapter to at least one end of each of a plurality of DNA fragments to generate tagged DNA fragments, wherein the adapter includes (i) an exogenous unique identifier (UID) selected from a pool of random UIDs which are in excess of the plurality of DNA fragments, and (ii) a priming site for polymerase chain reaction (PCR) amplification, wherein the priming site is distal to the region of interest and the UID;
splitting the tagged DNA fragments into a plurality of wells in which the tagged DNA fragments are added with forward and reverse primers complementary to the priming sites of the adapter, wherein at least one of the forward and reverse primers has an index attributable to a well or a group of wells and amplifying at least some of the tagged DNA fragments using the forward and reverse primers to generate families of amplicons, wherein amplicons in a family are represented by a common UID;
redundantly determining a nucleotide sequence of the region of interest and the UID in a respective at least part of the amplicons, wherein determined nucleotide sequences in a family are represented by a common UID;
comparing each of the determined nucleotide sequences in the family to a reference sequence; and
selecting at least one family among the families whose determined nucleotide sequences have a common mutation in at least 95% of the nucleotide sequences when compared to the reference sequence, wherein the detected DNA fragment comprising a region of interest comprises the determined nucleotide sequence of the common mutation present in at least 95% of the nucleotide sequences of the selected family.

2. The method according to claim 1 , wherein the step of attaching an adapter comprises attaching the adapter to the at least one end of each of at least some of the DNA fragments by a polymerase chain reaction or a ligase enzyme.

3. The method according to claim 1 , further comprising end-repairing ends of each DNA fragment.

4. The method according to claim 1 , further comprising end-repairing and A-tailing ends of the DNA fragments prior to attaching the adapter, wherein the adapter is attached to said at least one end of each of at least some of the DNA fragments by a ligase enzyme.

5. The method according to claim 1 , further comprising, prior to said attaching, providing analyte DNA, and enriching by capturing a subset of said analyte DNA to generate said plurality of DNA fragments, wherein said capturing employs capture oligonucleotides complementary to selected genes in said analyte DNA.

Assignees

• Univ Johns Hopkins

Inventors

• Vogelstein Bert
• Kinzler Kenneth W
• Papadopoulos Nickolas
• Kinde Isaac A

Classifications

• C12Q1/6806

  Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence) · CPC title

• C12Q2600/158

  Expression markers · CPC title

• C12Q1/6876

  Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes · CPC title

• C12Q2563/179

  the label being a nucleic acid · CPC title

• C12Q1/6869

  Methods for sequencing · CPC title